1-4 of 4
Joseph Uberti, MD
Close
Sort by
Journal Articles

T-Cell Large Granular Lymphocyte (T-LGL) Expansion Post Adult Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) – ‘A Prognostic Indicator for Improved Overall Survival’.

Mayur S Ramesh, MD, Zaid Al-Kadhimi, MD, Stephanie Mellon-Reppens, NP, Jason Valent, MD, Lawrence G Lum, MD, DSc, Lois Ayash, MD, Muneer H Abidi, MD, Voravit Ratanatharathorn, MD, Joseph Uberti, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2241.
https://doi.org/10.1182/blood.V114.22.2241.2241
Published: 2009
Journal Articles

Peri-Engraftment Mucositis Amongst Patients Receiving Intravenous Busulfan/Fludarabine as Conditioning Regimen for Allogeneic Hemopoietic Stem Cell Transplantation.

Abhinav Deol, MD, Palaniappan Manickam, MD, Joseph Uberti, MD, PhD, Voravit Ratanatharathorn, MD, Lawrence G. Lum, MD, DSC, Lois Ayash, MD, Muneer H. Abidi, MD, Judith Abrams, PhD, Zaid Al-Kadhimi, MD
Journal: Blood
Blood (2009) 114 (22): 3346.
https://doi.org/10.1182/blood.V114.22.3346.3346
Published: 2009
Journal Articles

Phase II Trial of Prochymal™ (Ex-Vivo Cultured Adult Human Mesenchymal Stem Cells) and Corticosteroids as Primary Treatment for Acute Graft-Vs-Host Disease (aGVHD).

Partow Kebriaei, MD, Luis Isola, MD, Erkut Bahceci, MD, H. Kent Holland, MD, Scott Rowley, MD, Joseph McGuirk, DO, Marcel Devetten, MD, Jan Jansen, MD, PhD, Roger Herzig, MD, Michael Schuster, MD, Joseph Uberti, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3231.
https://doi.org/10.1182/blood.V108.11.3231.3231
Published: 2006
Journal Articles

Fifteen-Year Follow up of Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndromes Using Busulfan-Based Regimens.

Ehab Atallah, MD, Joseph Uberti, MD, Lois Ayash, MD, Gail Bentley, MD, Jennifer VanDahm, MD, Voravit Ratanatharathorn, MD
Journal: Blood
Blood (2005) 106 (11): 5461.
https://doi.org/10.1182/blood.V106.11.5461.5461
Published: 2005